US Stock MarketDetailed Quotes
YMAB Y-mAbs Therapeutics
- 11.880
- +1.110+10.31%
Close Nov 27 16:00 ET
- 11.880
- 0.0000.00%
Post 20:01 ET
532.09MMarket Cap-22000P/E (TTM)
12.000High10.665Low225.03KVolume10.860Open10.770Pre Close2.62MTurnover0.83%Turnover RatioLossP/E (Static)44.79MShares20.90052wk High5.76P/B321.65MFloat Cap6.05052wk Low--Dividend TTM27.07MShs Float55.215Historical High--Div YieldTTM12.40%Amplitude2.700Historical Low11.664Avg Price1Lot Size
About Y-mAbs Therapeutics Company
Y-mAbs Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development and commercialization of antibody based therapeutic products for the treatment of cancer. Its services include discovery, protein engineering, clinical and regulatory. Y-mAbs Therapeutics was founded by Thomas Gad in April 2015 and is headquartered in New York, NY.
Company Profile
SymbolYMAB
Company NameY-mAbs Therapeutics
Listing DateSep 21, 2018
Issue Price16.00
Founded2015
CEOMr. Michael Rossi
MarketNASDAQ
Employees100
Fiscal Year Ends12-31
Address230 Park Avenue,Suite 3350
CityNew York
ProvinceNew York
CountryUnited States of America
Zip Code10169-0005
Phone1-646-885-8505
Websitehttp://www.ymabs.com
Company Executives
- Name
- Position
- Salary
- Michael Rossi
- Director, President and Chief Executive Officer
- 3.11M
- Thomas Gad
- Vice Chairman of the Board and Chief Business Officer
- 2.45M
- Vignesh Rajah
- Senior Vice President and Chief Medical Officer
- --
- Joris Wiel Jan Wilms
- Senior Vice President and Chief Operating Officer
- --
- Sue Smith
- Senior Vice President and Chief Commercial Officer
- 887.28K
- Peter P. Pfreundschuh
- Chief Financial Officer and Treasurer
- --
- Dr. Torben Lund-Hansen, PhD
- Senior Vice President and Chief Technical Officer
- --
- Dr. Steen Lisby
- Senior Vice President and Chief Scientific Officer
- --
- Dr. James I. Healy, M.D.,PhD
- Chairman of the Board
- 184.31K
- Dr. Mary A. Tagliaferri, M.D.
- Director
- --
- David N. Gill
- Independent Director
- 180.56K
- Dr. Ashutosh Tyagi, M.D.
- Independent Director
- 158.06K
- Laura J. Hamill
- Independent Director
- 168.06K
- Johan Wedell-Wedellsborg
- Independent Director
- 158.06K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
